Security Snapshot

agilon health, inc. - Common stock, $0.01 par value (AGL) Institutional Ownership

CUSIP: 00857U107

13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

3

Shares (Excl. Options)

365,695

Price

$7.91

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-358,822,263
Value change
-$293,068,805
Number of holders
3
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
16,608,126
SEC-reported price per share
$7.91
Insider filing price
$7.91
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • AGL - agilon health, inc. - Common stock, $0.01 par value is tracked under CUSIP 00857U107.
  • 3 institutions reported positions in Q1 2026.
  • 9 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 197 to 3 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $260,251,806 to $3,151,088.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 3 institutions filings for Q1 2026.

Open SEC evidence

Security key

00857U107

Latest holder period

Q1 2026

13F holders

3

13D/G owners

9

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
9
Security
AGL
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MORGAN STANLEY 12% $192,768,956 50,200,249 Morgan Stanley 31 Mar 2025
North Peak Capital Management, LLC 9.5% +86% $40,594,316 +$18,411,536 39,411,957 +83% North Peak Capital Management, LLC 30 Sep 2025
VANGUARD GROUP INC 4.4% -24% $12,618,229 -$4,112,087 18,321,808 -25% The Vanguard Group 31 Dec 2025
FMR LLC 3.7% -63% $15,838,857 -$24,084,688 15,377,531 -60% FMR LLC 30 Sep 2025
WELLINGTON MANAGEMENT GROUP LLP 3.6% -47% $57,549,684 -$51,420,591 14,986,897 -47% Wellington Management Group LLP 31 Mar 2025
Capital World Investors 2.6% -76% $9,333,531 -$29,857,186 10,852,943 -76% Capital World Investors 29 Aug 2025
Capital International Investors 2.4% -60% $22,060,815 -$27,739,262 9,892,742 -56% Capital International Investors 30 Jun 2025
GOLDMAN SACHS GROUP INC 6.1% $5,631,929 1,018,303 THE GOLDMAN SACHS GROUP, INC. 31 Mar 2026
AQR CAPITAL MANAGEMENT LLC 5.9% $5,391,863 974,897 AQR Capital Management, LLC 31 Mar 2026

As of 31 Mar 2026, 3 institutional investors reported holding 365,695 shares of agilon health, inc. - Common stock, $0.01 par value (AGL). This represents 2.2% of the company’s total 16,608,126 outstanding shares.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
20
Latest
Q1 2026
Rows shown
1-20 of 20
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 365,695 $3,151,088 -$293,068,805 $7.91 3
2025 Q4 377,603,391 $260,251,806 -$10,790,545 $0.69 197
2025 Q3 381,667,622 $393,148,245 -$40,840,326 $1.03 188
2025 Q2 399,328,682 $918,636,706 -$2,996,581 $2.30 204
2025 Q1 399,826,350 $1,730,807,498 -$76,575,360 $4.33 198
2024 Q4 416,234,592 $791,149,797 -$48,593,665 $1.90 183
2024 Q3 430,599,052 $1,691,470,202 -$113,061,378 $3.93 208
2024 Q2 455,653,328 $2,979,967,947 +$79,546,138 $6.54 201
2024 Q1 443,787,505 $2,706,552,672 -$123,526,322 $6.10 196
2023 Q4 448,445,736 $5,627,999,290 -$86,646,980 $12.55 191
2023 Q3 453,084,974 $8,047,230,241 +$191,740,226 $17.76 182
2023 Q2 441,924,134 $7,662,666,468 -$98,821,035 $17.34 185
2023 Q1 447,304,552 $10,625,730,982 +$380,606,408 $23.75 201
2022 Q4 431,582,727 $6,968,757,708 +$108,690,436 $16.14 168
2022 Q3 423,431,419 $9,916,406,555 +$176,516,049 $23.42 171
2022 Q2 413,012,885 $9,021,247,394 +$291,140,328 $21.83 142
2022 Q1 399,667,807 $10,129,841,658 +$205,624,833 $25.35 117
2021 Q4 390,547,332 $10,544,871,738 +$1,563,624,581 $27.00 125
2021 Q3 332,148,873 $8,681,146,469 +$10,635,889 $26.21 99
2021 Q2 330,692,941 $13,244,783,310 +$13,244,729,185 $40.57 92
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .